Sleep Apnea News and Research

RSS

Poor sleep may contribute to high insulin resistance in diabetic people

In the largest study of it kind to establish a link between sleep and diabetes, researchers found that people with diabetes who sleep poorly have higher insulin resistance, and a harder time controlling the disease.

3 May 2011

Sleep deprivation leads to decreased cognitive abilities: Study

A new study has shown that poor sleep as a person reaches middle age could mean that the brain is prematurely ageing, equivalent to a decline of up to seven years.

1 May 2011

USPTO grants Cortex patent for CX1739 AMPAKINE molecule

Cortex Pharmaceuticals, Inc. announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for a patent that protects its lead AMPAKINE® molecule, CX1739.

26 Apr 2011

Obesity impacts gene clock of cardiovascular system

Obese individuals typically suffer more medical problems than their leaner counterparts. They are more likely to be diagnosed with insulin resistance, diabetes, increased stress hormones, hypothyroidism, and sleep apnea. Researchers at the Georgia Health Sciences University in Augusta have also found the potential for something else, using an animal model.

12 Apr 2011

The Lancet publishes VIVUS 56-week QNEXA study results in obesity

VIVUS, Inc. today announced that detailed results from the 56-week CONQUER study were published in The Lancet evaluating the efficacy and safety of investigational drug QNEXA in 2,487 patients across 93 sites in the US.

11 Apr 2011

Treating obstructive sleep apnea in stroke patients improves recovery from stroke

A new study shows that patients in stroke rehabilitation treated for their co-existing obstructive sleep apnea (OSA) recovered better from stroke than those whose OSA was not treated.

6 Apr 2011

Sleep apnea people may face risk of suffering ischemic stroke

According to research presented at the School of Medicine and the University of Navarra Hospital by Dr. Roberto Muñoz, a physician of the Neurology Service of the Hospital Complex of Navarra, those persons with serious cases of sleep apnea have more than twice the possibility of suffering an ischemic stroke. Specifically, 2.5 times more.

6 Apr 2011

New risk calculator predicts risk of postoperative complications for bariatric surgery patients

A new risk calculator can predict the risk of postoperative complications occurring for individual bariatric surgery patients, according to a study published in the March issue of the Journal of the American College of Surgeons. The risk calculator will help in surgical decision-making and will help patients better understand what they can expect during recovery in order to prepare for a bariatric operation.

5 Apr 2011

Lilly's Axiron testosterone replacement therapy now available in US pharmacies

Eli Lilly and Company announced today that Axiron® (testosterone) topical solution is available in pharmacies throughout the United States. Axiron is a prescription medicine used to treat adult males that have low or no testosterone. Safety and efficacy of Axiron in males younger than 18 years of age have not been established.

1 Apr 2011

Sleep apnea along with excessive daytime sleepiness elevates risk of death in older adults

A study in the April 1 issue of the journal SLEEP suggests that the risk of death is more than two times higher in older adults who have sleep apnea and report struggling with excessive daytime sleepiness.

1 Apr 2011

USPTO issues patent to Somaxon's Silenor food effect

Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company, today announced that the U.S. Patent and Trademark Office has issued U.S. patent no. 7,915,307, entitled "Methods of Improving the Pharmacokinetics of Doxepin."

30 Mar 2011

Graymark Healthcare 2010 net revenues increase 30% to $22.8 million

Graymark Healthcare, Inc., the nation's second largest provider of diagnostic sleep services and an innovator in comprehensive care for obstructive sleep apnea (OSA), reported financial results for the fiscal year ended December 31, 2010.

28 Mar 2011

Rotech closes private offering of $290M in Senior Notes due 2018

Rotech Healthcare Inc. announced the closing of its previously announced offering of $290 million in aggregate principal amount of Senior Second Lien Notes due 2018.

19 Mar 2011

Cortex reports net loss of $0.01 per share for quarter ended December 31, 2010

Cortex Pharmaceuticals, Inc. reported a net loss applicable to common stock of $984,000, or $0.01 per share for the quarter ended December 31, 2010 compared with a net loss of $1,599,000, or $0.02 per share for the corresponding prior year period.

18 Mar 2011

Researchers to present latest findings about sleep disorders at Minneapolis Convention Center

Recent studies have linked sleep loss and sleep disorders to health problems such as depression, obesity, diabetes, high blood pressure and stroke. The latest findings in sleep research will be presented and discussed by more than 5,000 scientists and sleep specialists when the SLEEP 2011 25th Anniversary Meeting of the Associated Professional Sleep Societies LLC convenes at the Minneapolis Convention Center from June 13 to 15.

17 Mar 2011

Cortex enters agreement with Biovail to regain AMPAKINE assets and rights

Cortex Pharmaceuticals, Inc. announced that it has entered into an agreement with Biovail Laboratories International SRL, a wholly-owned subsidiary of Valeant Pharmaceuticals International, Inc., to regain the AMPAKINE® assets and rights related to respiratory depression.

16 Mar 2011

Patients with BPE may have Obstructive Sleep Apnea

Ben-Gurion University of the Negev researchers have shown that a significant number of patients with benign prostate enlargement may have Obstructive Sleep Apnea, which may be the reason for their night awakenings and urination.

16 Mar 2011

Bariatric surgery can lead to long-term weight loss, reduce cardiac risk factors in obese adults

Bariatric surgery can result in long-term weight loss and significant reductions in cardiac and other risk factors for some severely obese adults, according to a scientific statement from the American Heart Association.

15 Mar 2011

First POSE procedure using USGI's Incisionless Operating Platform performed at Ospedale All'Angelo

USGI Medical, Inc. announced that a prominent surgeon in Italy performed the first POSE procedure on patients for weight loss.

8 Mar 2011

FDA clears Breathe BT-V2S ventilator for COPD disease management

Breathe Technologies, Inc., a manufacturer of innovative technology solutions for people with respiratory conditions, including chronic obstructive pulmonary disease, announced today that it has received FDA clearance for use of the Breathe Technologies BT-V2S ventilator in the home setting.

8 Mar 2011